Webinar presentation: Medicinal cannabis - Changes to Special Access Scheme (SAS) and Authorised Prescriber applications, 22 November 2021
Date
Last updated
Disclaimer
These presentation papers are provided on the TGA's website solely for the purpose of indicating or suggesting what TGA representatives spoke about to the various conferences and seminars to which it relates. The papers are not legislative in nature and should not be taken to be statements of any law or policy in any way.
The Australian Government Department of Health (of which the TGA is a part) advises that (a) the presentation papers should not be relied upon in any way as representing a comprehensive description of regulatory requirements, and (b) cannot guarantee, and assumes no legal liability or responsibility for, the accuracy, currency or completeness of the information contained in the presentation paper.
Presentation
- Presented by: Petra Bismire, Thearapeutic Goods Administration
- Presented at: Online
- Presentation date: Monday 22 November 2021
- Presentation summary: Presentation explaining how medical practitioners can apply to access certain medicinal cannabis medicines via the Authorised Prescriber Established History of use pathway (no ethics committee approval required) and guide you through applying to prescribe 'unapproved' medicinal cannabis products by category of active ingredient.
Topics
Related content
-
Information on the Office of Gene Technology Regulator’s Cost Recovery Implementation Statement
This webinar provides an overview of the draft Cost Recovery Implementation Statement (CRIS), including the proposed cost recovery model, implementation approach, and key considerations for stakeholders. -
TGA Digital Transformation for Industry
Join us for an interactive webinar to learn about the TGA's Digital Transformation Program and preview the new TGA Business Services (TBS) experience ahead of its planned 2027 launch.